Sublingual Semaglutide As A SubMagna Delivery System For Weight Loss

Sublingual semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as a promising therapeutic option for weight loss.

In recent years, the prevalence of obesity has reached alarming levels globally, necessitating innovative approaches for effective weight management.